The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: Consensus document of the Joint Program for Neurodegenerative Diseases Working Group

Alzheimer's Research and Therapy

Volumn 9, Issue 1, 2017, Pages

  Costa, Alberto ^a,b   Bak, Thomas ^c   Caffarra, Paolo ^d   Caltagirone, Carlo ^b,e   Ceccaldi, Mathieu ^f,g   Collette, Fabienne ^h,i   Crutch, Sebastian ^j   Della Sala, Sergio ^b   Démonet, Jean François ^k   Dubois, Bruno ^l   Duzel, Emrah ^j,m   Nestor, Peter ^m   Papageorgiou, Sokratis G ⁿ   Salmon, Eric ^i,o   Sikkes, Sietske ^p   Tiraboschi, Pietro ^q   Van Der Flier, Wiesje M ^p   Visser, Pieter Jelle ^r   Cappa, Stefano F ^s,t  

^a NICCOLÒ CUSANO UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f TIMONE HOSPITAL   (France)

^g AIX MARSEILLE UNIVERSITY   (France)

^h FNRS   (Belgium)

ⁱ UNIVERSITY OF LIÈGE   (Belgium)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^m GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

ⁿ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^o UNIVERSITY OF LIÈGE   (Belgium)

^p VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^q DEPARTMENT OF NEUROSURGERY   (Italy)

^r MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^s SCUOLA UNIVERSITARIA SUPERIORE IUSS PAVIA   (Italy)

^t IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

more..

Author keywords

Behavioural assessment; Cognitive assessment; European research; Longitudinal studies; Neurodegenerative dementia; Neuropsychological tests

Indexed keywords

ALZHEIMER DISEASE ASSESSMENT SCALE; BEHAVIOR ASSESSMENT; BEHAVIOR DISORDER; COGNITION; DAILY LIFE ACTIVITY; DEGENERATIVE DISEASE; DEMENTIA; DEMENTIA ASSESSMENT; DEPTH PERCEPTION; EPISODIC MEMORY; EUROPE; EXECUTIVE FUNCTION; FUNCTIONAL STATUS; HUMAN; LANGUAGE ABILITY; LEARNING; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MOTOR DYSFUNCTION; NEURODEGENERATIVE DEMENTIA; NEUROPSYCHOLOGICAL TEST; PSYCHOMETRY; RELIABILITY; REVIEW; STANDARDIZATION; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDITY; VISUAL IMPAIRMENT; CONSENSUS DEVELOPMENT;

DEMENTIA; EUROPE; HUMANS; NEUROPSYCHOLOGICAL TESTS;

EID: 85018507140     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-017-0254-x     Document Type: Review

References (122)

1. Daffner KR, Gale SA, Barrett AM, Boeve BF, Chatterjee A, Coslett HB, et al. Improving clinical cognitive testing: report of the AAN Behavioral Neurology Section Workgroup. Neurology. 2015;85:910-8. doi: 10.1212/WNL.0000000000001763.
2. Wilcock GK, Hope RA, Brooks DN, Lantos PL, Oppenheimer C, Reynolds GP, et al. Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. J Neurol Neurosurg Psychiatry. 1989;52:693-700.
3. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-41.
4. Diaz PR, Gregório GP, Ribera Casado M, Reynish E, Ousset JP, Vellas B, et al. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey. Int J Geriatr Psychiatry. 2005;20:744-8.
5. Maruta C, Guerreiro M, de Mendonça A, Hort J, Scheltens P. The use of neuropsychological tests across Europe: the need for a consensus in the use of assessment tools for dementia. Eur J Neurol. 2011;18:279-85.
6. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614-29. Erratum in: Lancet Neurol. 2014;13:757.
7. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011;7:263-9.
8. Crutch SJ, Schott JM, Rabinovici GD, Boeve BF, Cappa SF, Dickerson BC, et al. Shining a light on posterior cortical atrophy. Alzheimers Dement. 2013;9:463-5.
9. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456-77.
10. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006-14.
11. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State" a practical method for grading the cognitive state of patients for the clinicians. J Psychiat Res. 1975;12:189-19.
12. Marioni RE, Chatfield M, Brayne C, Matthews FE, Medical Research Council Cognitive Function and Ageing Study Group. The reliability of assigning individuals to cognitive states using the Mini Mental-State Examination: a population-based prospective cohort study. BMC Med Res Methodol. 2011;11:127. doi: 10.1186/1471-2288-11-127.
13. Mitolo M, Salmon DP, Gardini S, Galasko D, Grossi E, Caffarra P. The New Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease. J Alzheimers Dis. 2014;39(4):823-32. doi: 10.3233/JAD-131403.
14. Nieuwenhuis-Mark RE. The death knoll for the MMSE: has it outlived its purpose? J Geriatr Psychiatry Neurol. 2010;23:151-7. doi: 10.1177/0891988710363714.
15. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-9.
16. Freitas S, Simões MR, Alves L, Santana I. Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27:37-43. doi: 10.1097/WAD.0b013e3182420bfe.
17. Dubois B, Slachevsky A, Litvan I, Pillon BF. The FAB - a frontal assessment battery at bedside. Neurology. 2000;55:1621-6.
18. Castiglioni S, Pelati O, Zuffi M, Somalvico F, Marino L, Tentorio T, et al. The frontal assessment battery does not differentiate frontotemporal dementia from Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;22:125-31.
19. Lipton AM, Ohman KA, Womack KB, Hynan LS, Ninman ET, Lacritz LH. Subscores of the FAB differentiate frontotemporal lobar degeneration from AD. Neurology. 2005;65:726-31.
20. Doraiswamy PM, Krishen A, Stallone F, Martin WL, Potts NL, Metz A, et al. Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of education. Neurology. 1995;45:1980-4.
21. Verhey FR, Huppert FA, Korten EC, Houx P, de Vugt M, van Lang N, et al. Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in Dementia. Age Ageing. 2003;32:534-40.
22. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke's Cognitive Examination Revised (ACER): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078-85.
23. Rittman T, Ghosh BC, McColgan P, Breen DP, Evans J, Williams-Gray CH, et al. The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry. 2013;84:544-51.
24. Schmidt R, Freidl W, Fazekas F, Reinhart B, Grieshofer P, Koch M, et al. The Mattis Dementia Rating Scale. Normative data from 1,001 healthy volunteers. Neurology. 1994;44:964-6.
25. Pirogovsky E, Schiehser DM, Litvan I, Obtera KM, Burke MM, Lessig SL, et al. The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment. Parkinsonism Relat Disord. 2014;20:627-31.
26. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive "vital signs" measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021-7.
27. Lowndes GJ, Saling MM, Ames D, Chiu E, Gonzalez LM, Savage GR. Recall and recognition of verbal paired associates in early Alzheimer's disease. J Int Neuropsychol Soc. 2008;14:591-600.
28. Savage RM, Gouvier WD. Rey Auditory-Verbal Learning Test: the effects of age and gender, and norms for delayed recall and story recognition trials. Arch Clin Neuropsychol. 1992;7:407-14.
29. Dubois B, Touchon J, Portet F, Ousset PJ, Vellas B, Michel B. "The 5 words": a simple and sensitive test for the diagnosis of Alzheimer's disease. Presse Med. 2002;31:1696-9.
30. Grober E, Sanders AE, Hall C, Lipton RB. Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis Assoc Disord. 2010;24:284-90.
31. Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, et al. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology. 2012;78:379-86.
32. Barbeau E, Didic M, Tramoni E, Felician O, Joubert S, Sontheimer A, et al. Evaluation of visual recognition memory in MCI patients. Neurology. 2004;62:1317-22.
33. Parra MA, Abrahams S, Fabi K, Logie R, Luzzi S, Della SS. Short-term memory binding deficits in Alzheimer's disease. Brain. 2009;132:1057-66.
34. Della Sala S, Parra MA, Fabi K, Luzzi S, Abrahams S. Short-term memory binding is impaired in AD but not in non-AD dementias. Neuropsychologia. 2012;50:833-40.
35. Papageorgiou SG, Economou A, Routsis C. The 5 Objects Test: a novel, minimal-language, memory screening test. J Neurol. 2014;261:422-31.
36. Costa A, Fadda L, Perri R, Brisindi M, Lombardi MG, Caltagirone C, et al. Sensitivity of a time-based prospective memory procedure in the assessment of amnestic mild cognitive impairment. J Alzheimers Dis. 2015;44:63-7.
37. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology. 1994;44:1427-32.
38. Locascio JJ, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol. 1995;52:1087-99.
39. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lee & Febiger; 1983.
40. Katsumata Y, Mathews M, Abner EL, Jicha GA, Caban-Holt A, Smith CD, et al. Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort. Dement Geriatr Cogn Disord. 2015;39:215-27. doi: 10.1159/000370108.
41. McKenna P, Warrington EK. Testing for nominal dysphasia. J Neurol Neurosurg Psychiatry. 1980;43:781-8.
42. Huber W. Aachener aphasie test (AAT). Verlag für Psychologie: Dr. CJ Hogrefe: 1983
43. De Jager CA, Hogervorst E, Combrinck M, Budge MM. Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med. 2003;33:1039-50.
44. Brambati SM, Myers D, Wilson A, Rankin KP, Allison SC, Rosen HJ, et al. The anatomy of category-specific object naming in neurodegenerative diseases. J Cogn Neurosci. 2006;18:1644-53.
45. Stuss DT, Alexander MP, Hamer L, Palumbo C, Dempster R, Binns M, et al. The effects of focal anterior and posterior brain lesions on verbal fluency. J Int Neuropsychol Soc. 1998;4:265-78.
46. Howard D, Patterson KE. The Pyramids and Palm Trees Test: a test of semantic access from words and pictures. England: Thames Valley Test Company; 1992.
47. Bozeat S, Lambon Ralph MA, Patterson K, Garrard P, Hodges JR. Non-verbal semantic impairment in semantic dementia. Neuropsychologia. 2000;38:1207-15.
48. Wilson SM, Henry ML, Besbris M, Ogar JM, Dronkers NF, Jarrold W, et al. Connected speech production in three variants of primary progressive aphasia. Brain. 2010;133:2069-88.
49. Weintraub S, Mesulam MM, Wieneke C, Rademaker A, Rogalski EJ, Thompson CK. The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen. 2009;24:408-16. doi: 10.1177/1533317509343104.
50. De Renzi E, Vignolo LA. The Token Test: a sensitive test to detect receptive disturbances in aphasics. Brain. 1962;85:665-78.
51. Bishop DVM. Comprehension of English syntax by profoundly deaf children. J Child Psychol Psychiatry. 1983;24:415-34.
52. Curtiss S. Curtiss-Yamada comprehensive language evaluation. Unpublished test, Los Angeles: UCLA; 1988.
53. Nelson HE, Willison J. The Nelson Adult Reading Test (NART): test manual. Windsor, England: NFER Nelson; 1991.
54. Adlam AL, Patterson K, Bozeat S, Hodges JR. The Cambridge Semantic Memory Test Battery: detection of semantic deficits in semantic dementia and Alzheimer's disease. Neurocase. 2010;16:193-207.
55. Savage S, Hsieh S, Leslie F, Foxe D, Piguet O, Hodges JR. Distinguishing subtypes in primary progressive aphasia: application of the Sydney language battery. Dement Geriatr Cogn Dis. 2013;35:208-18.
56. Blomert L, Kean M, Koster C, Schokker J. Amsterdam - Nijmegen everyday language test: construction, reliability and validity. Aphasiology. 1994;8:381-407.
57. Chan RC, Shum D, Toulopoulou T, Chen EY. Assessment of executive functions: review of instruments and identification of critical issues. Arch Clin Neuropsychol. 2008;23:201-16.
58. Torralva T, Cuitino MM, Manes F. Neuropsychological assessment of frontotemporal dementia. In: Dickerson BC, editor. Hodges' frontotemporal dementia. Cambridge: Cambridge University Press; 2016. p. 55.
59. Stopford CL, Thompson JC, Neary D, Richardson AMT, Snowden JS. Working memory, attention and executive function in Alzheimer's disease and frontotemporal dementia. Cortex. 2012;48:429-46.
60. Collette F, Schmidt C, Scherrer C, Adam S, Salmon E. Specificity of inhibitory deficits in normal aging and Alzheimer's disease. Neurobiol Aging. 2009;30:875-89.
61. Collette F, Amieva H, Adam S, Hogge M, Van der Linden M, Fabrigoule C, et al. Comparison of inhibitory functioning in mild Alzheimer's disease and frontotemporal dementia. Cortex. 2007;43:866-74.
62. Lagarde J, Valabrègue R, Corvol JC, Garcin B, Volle E, Le Ber I, et al. Why do patients with neurodegenerative frontal syndrome fail to answer: 'in what way are an orange and a banana alike?'. Brain. 2015;138:456-71.
63. Burgess PW, Alderman N, Evans J, Emslie H, Wilson BA. The ecological validity of tests of executive functions. J Int Neuropsychol Soc. 1998;4:547-58.
64. Torralva T, Roca M, Gleichgerrcht E, Bekinschtein T, Manes F. A neuropsychological battery to detect specific executive and social cognitive impairments in early frontotemporal dementia. Brain. 2009;132:1299-309.
65. Godefroy O, GREFEX. Fonctions exécutives et pathologies neurologiques et psychiatriques. Evaluation en pratique clinique. Marseille: Solal; 2008.
66. Wilson BA, Evans JJ, Emslie H, Alderman N, Burgess P. The development of an ecologically valid test for assessing patients with a dysexecutive syndrome. Neuropsychol Rehabil. 1998;8:213-28.
67. Ekman P, Friesen WV, Ellsworth P. Emotion in the human face. New York: Pergamon; 1972.
68. Bechara A, Tranel D, Damasio H. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain. 2000;123:2189-202.
69. Bertoux M, Funkiewiez A, O'Callaghan C, Dubois B, Hornberger M. Sensitivity and specificity of ventromedial prefrontal cortex tests in behavioral variant frontotemporal dementia. Alzheimer's Dement. 2013;9:S84-94.
70. Bertoux M, Volle E, de Souza LC, Funkiewiez A, Dubois B, Habert MO. Neural correlates of the mini-SEA (Social cognition and Emotional Assessment) in behavioral variant frontotemporal dementia. Brain Imaging Behav. 2014;8:1-6.
71. Hutchison KA, Balota DA, Duchek JM. The utility of Stroop Task switching as a marker for early stage Alzheimer's disease. Psychol Aging. 2010;25:545-59.
72. Reitan R. Trail-making test. Arizona: Reitan Neuropsychology Laboratory; 1970.
73. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test Manual: revised and expanded. Odessa, FL: Psychological Assessment Resources; 1993.
74. Henry JD, Crawford JR, Phillips LH. Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis. Neuropsychologia. 2004;2:1212-22.
75. Shakespeare TJ, Yong KX, Foxe D, Hodges J, Crutch SJ. Pronounced impairment of everyday skills and self-care in posterior cortical atrophy. J Alzheimers Dis. 2015;43:381-4. doi: 10.3233/JAD-141071.
76. Goodale MA, Milner AD. Separate visual pathways for perception and action. Trends Neurosci. 1992;15:20-5.
77. Lehmann M, Barnes J, Ridgway GR, Wattam-Bell J, Warrington EK, Fox NC, et al. Basic visual function and cortical thickness patterns in posterior cortical atrophy. Cereb Cortex. 2011;212122-32. doi: 10.1093/cercor/bhq287
78. Twum M, Parenté R. Role of imagery and verbal labeling in the performance of paired associates tasks by persons with closed head injury. J Clin Exp Neuropsychol. 1994;16:630-9.
79. Warrington EK. Studies of retrograde memory: a long-term view. Proc Natl Acad Sci U S A. 1996;93:13523-6.
80. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-72. Erratum in: Neurology. 2005; 65;1992.
81. Mathew R, Bak TH, Hodges JR. Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry. 2012;83:405-10.
82. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012;11:170-8.
83. Warrington EK, James M. A new test of object decision: 2D silhouettes featuring a minimal view. Cortex. 1991;27:370-83.
84. Quental NB, Brucki SM, Bueno OF. Visuospatial function in early Alzheimer's disease - the use of the Visual Object and Space Perception (VOSP) battery. PLoS One. 2013;8:e68398. doi: 10.1371/journal.pone.0068398.
85. Riddoch MJ, Humphreys GW. The Birmingham Object Recognition Battery (BORB). London: Erlbaum; 1993.
86. Benton AL, Varney NR, Hamsher KS. Visuospatial judgment: a clinical test. Arch Neurol. 1978;35:364-7.
87. Simard M, van Reekum R, Myran D. Visuospatial impairment in dementia with Lewy bodies and Alzheimer's disease: a process analysis approach. Int J Geriatr Psychiatry. 2003;18:387-91.
88. Osterrieth PA. Le test de copie d'une figure complex: contribution à l'étude de la perception et de la memoir. Arch Psychol. 1944;30:286-356.
89. Siri S, Benaglio I, Frigerio A, Binetti G, Cappa SF. A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementiaand Alzheimer's disease. Eur J Neurol. 2001;8:125-32.
90. Possin KL, Laluz VR, Alcantar OZ, Miller BL, Kramer JH. Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementia. Neuropsychologia. 2011;49:43-8. doi: 10.1016/j.neuropsychologia.2010.10.026.
91. Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012. doi: 10.3389/fneur.2012.00073.
92. Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis. 2009;18:11-30.
93. Spalletta G, Musicco M, Padovani A, Rozzini L, Perri R, Fadda L, et al. Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer. Am J Geriatr Psychiatry. 2010;18:1026-35. doi: 10.1097/JGP.0b013e3181d6b68d.
94. Kertesz A, Davidson W, Fox H. Frontal Behavioral Inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29-36.
95. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry. 1987;48 suppl 5:9-1.
96. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48 suppl 6:10-6.
97. Suárez-González A, Serrano-Pozo A, Arroyo-Anlló EM, Franco-Macías E, Polo J, García-Solís D, et al. Utility of neuropsychiatric tools in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease: quantitative and qualitative findings. Int Psychogeriatr. 2014;26:453-61. doi: 10.1017/S1041610213002068.
98. Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, et al. Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. Int Psychogeriatr. 2015;27:2059-67. doi: 10.1017/S1041610215001106.
99. Atri A, Hendrix SB, Pejović V, Hofbauer RK, Edwards J, Molinuevo JL, Graham SM. Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis. Alzheimers Res Ther. 2015;7:28. doi: 10.1186/s13195-015-0109-2.
100. De Medeiros K, Robert P, Gauthier S, Stella F, Politis A, Leoutsakos J, et al. The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr. 2010;22:984-94.
101. Radakovic R, Abrahams S. Developing a new apathy measurement scale: Dimensional Apathy Scale. Psychiatry Res. 2014;219:658-63. doi: 10.1016/j.psychres.2014.06.010.
102. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiat Res. 1983;17:37-49.
103. Lesourd M, Le Gall D, Baumard J, Croisile B, Jarry C, Osiurak F. Apraxia and Alzheimer's disease: review and perspectives. Neuropsychol Rev. 2013;23:234-56. doi: 10.1007/s11065-013-9235-4.
104. Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, et al. Motor signs during the course of Alzheimer disease. Neurology. 2004;28(63):975-82.
105. Ryan NS, Shakespeare TJ, Lehmann M, Keihaninejad S, Nicholas JM, Leung KK, et al. Motor features in posterior cortical atrophy and their imaging correlates. Neurobiol Aging. 2014;35:2845-57. doi: 10.1016/j.neurobiolaging.2014.05.028.
106. Johnen A, Frommeyer J, Modes F, Wiendl H, Duning T, Lohmann H. Dementia Apraxia Test (DATE): a brief tool to differentiate behavioral variant frontotemporal dementia from Alzheimer's. J Alzheimers Dis. 2015;49:593-605. doi: 10.3233/JAD-150447.
107. Bak T, Bennett G, Symonds A, PAI S. Motor symptoms in healthy ageing and dementia: frequency, patterns and the relation between motor and cognitive functions. Eur J Neurol. 2015;2 Suppl 1:94.
108. Petersen R, Doody R, Kurz A, Mohs R, Morris J, Rabins P, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-92.
109. Sikkes SAM, Visser PJ, Knol DL, de Lange-de Klerk ESM, Tsolaki M, Frisoni GB, et al. Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study. J Am Geriatr Soc. 2011;59:2273-81.
110. Jekel K, Damian M, Wattmo C, Hausner L, Bullock R, Connelly PJ, et al. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review. Alzheimers Res Ther. 2015;7:17.
111. Desai AK, Grossberg GT, Sheth DN. Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment. CNS Drugs. 2004;18:853-75.
112. Sikkes SAM, de Lange-de Klerk ESM, Pijnenburg YAL, Scheltens P, Uitdehaag BMJ. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry. 2009;80:7-12.
113. Gold DA. An examination of instrumental activities of daily living assessment in older adults and mild cognitive impairment. J Clin Exp Neuropsychol. 2012;34:11-34.
114. Marshall G, Amariglio RE, Sperling R, Rentz DM. Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease? Neurodegener Dis Manag. 2012;2:483-91.
115. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-86.
116. Vergara I, Bilbao A, Orive M, Garcia-Gutierrez S, Navarro G, Quintana JM. Validation of the Spanish version of the Lawton IADL Scale for its application in elderly people. Health Qual Life Outcomes. 2012;10:130. doi: 10.1186/1477-7525-10-130.
117. Sikkes SAM, Pijnenburg YAL, Knol DL, de Lange-de Klerk ESM, Scheltens P, Uitdehaag BMJ. Assessment of instrumental activities of daily living in dementia: diagnostic value of the Amsterdam Instrumental Activities of Daily Living Questionnaire. J Geriatr Psychiatry Neurol. 2013;26:244-50.
118. Koster N, Knol DL, Uitdehaag BMJ, Scheltens P, Sikkes SAM. The sensitivity to change over time of the Amsterdam IADL Questionnaire. Alzheimer's Dement. 2015;11:1231-40. doi: 10.1016/j.jalz.2014.10.006.
119. Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 2008;22:531-44.
120. Walsh SP, Raman R, Jones KB, Aisen PS. ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI). Alzheimer Dis Assoc Disord. 2006;20(4 Suppl 3):170-8.
121. Logie R, Parra Rodriguez M, Della SS. From cognitive science to dementia assessment. Behav Brain Sc. 2015;2:81-91.
122. Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisoni GB, et al. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology. 2008;30:254-65.